Premium
Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma
Author(s) -
MELIA J.,
COOPER E.J.,
FROST T.,
GRAHAMBROWN R.,
HUNTER J.,
MARSDEN A.,
VIVIER A.,
WHITE J.,
WHITEHEAD S.,
WARIN A.P.,
WROUGHTON M.,
ELLMAN R.,
CHAMBERLAIN J.
Publication year - 1995
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1995.tb08675.x
Subject(s) - medicine , incidence (geometry) , melanoma , demography , population , welsh , cancer , epidemiology , cancer registry , pathology , environmental health , geography , physics , archaeology , cancer research , sociology , optics
Summary The effect on the detection and characteristics of melanoma, resulting from the Cancer Research Campaign's health education programme to promote the early detection of melanoma in the general population, was studied from 1987 to 1989. The seven study areas in England and Scotland yield a target population of 3.6 million. Data were collected from local clinic‐based registers, pathology laboratories, and the cancer registries. The average annual incidence rates of melanoma were seven and 12 per 10 5 in males and females, respectively, age‐standardized to England and Wales, 1988. These rates are similar to the national figures for Scotland, where there is a national melanoma register, but higher than those reported by the English and Welsh cancer registries. The incidence was significantly higher in females than males (P<(0.001), and increased with age. Fifty‐three per cent and 65% of cases in males and females, respectively, were thin (Breslow thickness ≤1.5 mm), similar to the national figures from Scotland. No significant decrease in the incidence of late‐stage tumours was found in either sex as a result of the campaign. Because of difficulties with ascertainment of cases in England, the main evaluation will focus on future trends in mortality rates for melanoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom